Page 278 - Eshre Final Programme 2015

P-693 GnRHa trigger in Asian oocyte donors co-treated with a GnRH antagonist – the first randomized GnRHa trigger dose finding study
V. Lan1, H. Tuong2, P. Humaidan3
1University of Medicine and Pharmacy at Ho Chi Minh City, Department of OB/GYN, Ho Chi Minh, Vietnam
2Vietnam National University Ho Chi Minh City, Research Center for Genetics and Reproductive Health School of Medicine, Ho Chi Minh, Vietnam
3Faculty of Health Aarhus University, The Fertility Clinic Skive Regional Hospital, Skive, Denmark
P-694 Dehydroepiandrosterone (DHEA) treatment for poor responders in IVF patients: A prospective Randomised Controlled Trial.
V. Viardot-Foucault1, B.C. Tai2, X.W. Ng1, Z.J. Chen2, M.S.K. Lau1, S. Nadarajah1, H.H. Tan1, J.K.Y. Chan1
1KK Women's and Children's Hospital, Reproductive Medicine, Singapore, Singapore Rep. of 2National University Health System, Investigational Medicine Unit, Singapore, Singapore Rep. of
P-695 Human Immunodeficiency Virus infected women and ovarian reserve: a matched case-control study examining serum anti-mullerian hormone
D. De Montlaur1, P. Santulli2, M.C. Lafay Pillet2, V. Gayet2, V. Blanchet2, J. Gonnot2, D. De Ziegler2, C. Chapron2
1CHU de Poitiers service de gynécologie, 86000, Poitiers, France
2Department "Development Reproduction and Cancer" Institut Cochin INSERM U1016 Université Paris Descartes Sorbonne Paris Cité, Paris, France
P-696 Polyglycine-containing protein (FMRpolyG) may play a role in the pathogenesis of fragile X associated premature ovarian insufficiency (FXPOI) in FMR1 premutation carriers
Y. Cohen1, O. Dratviman-Storobinsky1, A. Aizer1, J. Dor1, R. Orvieto1, S.E. Elizur1
1Sheba Medical Center, IVF unit, Ramat-Gan, Israel
P-697 Hormonal profile of follicular fluid from mature follicles in mild stimulation and controlled ovarian hyperstimulation IVF cycles in POR patients
X.L. Zhang1, R. Huang1, B. Wang1, X. Yang1, X.Y. Liang1
1Sixth affiliated hospital of Sun Yat-sen University, Reproductive medicine center, Guangzhou Guangdong, China
P-698 Validation of a new prognostic biomarker to enhance overall implantation rates in an egg donation (ED) program through cancellation of bad prognosis stimulations before triggering.
S. Rogel1, N. Szlärb1, M. Guijarro2, M. Fernández2, J. Aizpurua1
1IVF Spain, Gynecology, Alicante, Spain 2IVF Spain, Embryology, Alicante, Spain
P-699 A prospective randomised controlled trial (RCT) on the role of AMH tailored stimulation protocols (Agonist or Antagonist),in improving IVF outcome in previous failed cycles
M. Singh1, R. Singh1, A. Jindal1, P.C. Jindal1
1Bhopal Test Tube Baby Centre, Gynaecology and Obstetrics, Bhopal, India
278